Caption Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,900
Closed -$64.4M 1842
2025
Q4
$64.4M Buy
+59,900
New +$57.3M 0.44% 45
2025
Q3
Sell
-19,200
Closed -$15M 1876
2025
Q2
$15M Buy
+19,200
New +$14.9M 0.17% 127
2024
Q1
Sell
-20,000
Closed -$11.7M 1463
2023
Q4
$11.7M Buy
+20,000
New +$11.7M 0.16% 160
2022
Q4
Sell
-36,700
Closed -$11.9M 1514
2022
Q3
$11.9M Buy
+36,700
New +$11.6M 0.16% 133
2018
Q2
Sell
-35,300
Closed -$2.73M 422
2018
Q1
$2.73M Buy
+35,300
New +$2.84M 0.39% 78

Other funds holding LLY

Caption Management's LLY Position: Q1 2026 in Review

Caption Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 5,240 shares — an estimated $5.63M sold.

Caption Management first reported a position in LLY in Q1 2018 and held it in 6 quarters. The position peaked at $6.82M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Caption Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 5,240 Eli Lilly shares in Q1 2026, an estimated $5.63M.
  • Caption Management first reported a position in Eli Lilly in Q1 2018 and held it in 6 quarters.
  • Caption Management's Eli Lilly position peaked at $6.82M in Q4 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.